Contact
Please use this form to send email to PR contact of this press release:
BTAI CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages BioXcel Therapeutics (BTAI) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Lawsuit Pending
TO: